Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EBT (2024 - 2025)

Beta Bionics' EBT history spans 2 years, with the latest figure at -$13.5 million for Q4 2025.

  • For Q4 2025, EBT fell 11.42% year-over-year to -$13.5 million; the TTM value through Dec 2025 reached -$60.7 million, down 46.94%, while the annual FY2025 figure was -$60.7 million, 46.94% down from the prior year.
  • EBT for Q4 2025 was -$13.5 million at Beta Bionics, up from -$14.2 million in the prior quarter.
  • Across five years, EBT topped out at -$8.3 million in Q1 2024 and bottomed at -$16.9 million in Q2 2025.